drugset / Trial / NCT07843862
A Study of HRS-4729 Injection in Participants With Type 2 Diabetes
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main purpose of this study is to evaluate the efficacy and safety of HRS-4729 Injection in participants with type 2 diabetes who failed to achieve adequate glycemic control on diet and exercise alone or on a stable dose of metformin.
Timeline
- Start
- 2026-10
- Primary completion
- 2027-04
- Completion
- 2027-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-4729 | Unknown | — | — |
| Comparator | Mazdutide | Protein / enzyme biologic | — | — |